Anti-Migratory and Cytotoxic Activities of [Ga(8-hydroxyquinolinato)3]: Roles of Endogenous Cu(II) and Drug-Induced Phenotypic Changes
Chemistry (Weinheim an der Bergstrasse, Germany)(2023)
Abstract
As shown by IncuCyte Zoom imaging proliferation assays, invasive triple-negative human breast MDA-MB-231 cancer cells treated with sub-toxic doses (5.0-20 mu M, 72h) of [GaQ(3)] (Q=8-hydroxyquinolinato) caused profound morphological changes and inhibition of cell migration, which were likely due to terminal cell differentiation or similar phenotypical change. This is the first demonstration of potential use of a metal complex in differentiation anti-cancer therapy. Additionally, a trace amount of Cu(II) (0.20 mu M) added to the medium dramatically increased [GaQ(3)] cytotoxicity (IC50 similar to 2 mu M, 72h) due to its partial dissociation and the action of the HQ ligand as a Cu(II) ionophore, as shown with electrospray mass spectrometry and fluorescence spectroscopy assays in the medium. Hence, cytotoxicity of [GaQ(3)] is strongly linked to ligand binding of essential metal ions in the medium, for example, Cu(II). Appropriate delivery mechanisms of such complexes and their ligands could enable a powerful new triple therapeutic approach for cancer chemotherapy, including cytotoxicity against primary tumour, arrest of metastases, and activation of innate and adaptive immune responses.
MoreTranslated text
Key words
copper(II) cytotoxicity,gallium(III) anti-cancer drug,8-hydroxyquinoline ionophore,terminal differentiation,triple negative MDA-MB-231 breast cancer cells
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined